文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Oral and nasal microbiota in Parkinson's disease.

作者信息

Pereira Pedro A B, Aho Velma T E, Paulin Lars, Pekkonen Eero, Auvinen Petri, Scheperjans Filip

机构信息

Institute of Biotechnology, DNA Sequencing and Genomics Laboratory, University of Helsinki, Viikinkaari 5D, 00014, Finland.

Department of Neurology, Helsinki University Hospital, and Clinical Neurosciences, Neurology, University of Helsinki, Haartmaninkatu 4, 00290 Helsinki, Finland.

出版信息

Parkinsonism Relat Disord. 2017 May;38:61-67. doi: 10.1016/j.parkreldis.2017.02.026. Epub 2017 Feb 22.


DOI:10.1016/j.parkreldis.2017.02.026
PMID:28259623
Abstract

INTRODUCTION: Parkinson's disease (PD) is associated with neuropathological changes in olfactory and gastrointestinal tissues, and PD patients frequently suffer from hyposmia, hyposalivation, and dysphagia. Since hyposmia and gastrointestinal dysfunction are frequently premotor symptoms, it has been speculated that an external, for example microbial, agent could trigger the pathologic process in the corresponding organs, subsequently spreading to the central nervous system. We recently showed evidence for compositional differences between the fecal microbiota of PD patients and control subjects. In this study, our objective was to explore a possible connection between nasal and oral microbiota and PD. METHODS: We compared the oral and nasal bacterial communities of PD patients (oral: n = 72, nasal: n = 69) and control subjects (oral: n = 76, nasal: n = 67) using a 16S rRNA gene amplicon sequencing approach. RESULTS: Oral and nasal microbiota differed markedly from each other, with no notable similarity within subjects. Oral microbiota of PD patients and control subjects had differences in beta diversity and abundances of individual bacterial taxa. An increase in the abundance of opportunistic oral pathogens was detected in males, both with and without PD. Our data did not reveal convincing differences between the nasal microbiota of control subjects and PD patients. CONCLUSION: The oral microbiome deserves additional research regarding its connection to PD and its biomarker potential. The higher abundance of oral pathogens in men underlines the importance of monitoring and promoting male dental health.

摘要

相似文献

[1]
Oral and nasal microbiota in Parkinson's disease.

Parkinsonism Relat Disord. 2017-5

[2]
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.

Mov Disord. 2017-8-26

[3]
Gut, oral and nasal microbiota and Parkinson's disease.

Microb Cell Fact. 2020-2-27

[4]
Gut microbiota are related to Parkinson's disease and clinical phenotype.

Mov Disord. 2015-3

[5]
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.

Genome Med. 2017-4-28

[6]
The Role of the Western Diet and Oral Microbiota in Parkinson's Disease.

Nutrients. 2022-1-14

[7]
The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function.

PLoS One. 2019-6-27

[8]
Deep nasal sinus cavity microbiota dysbiosis in Parkinson's disease.

NPJ Parkinsons Dis. 2021-12-8

[9]
Gut microbiota in patients with Parkinson's disease in southern China.

Parkinsonism Relat Disord. 2018-8

[10]
Approaching the Gut and Nasal Microbiota in Parkinson's Disease in the Era of the Seed Amplification Assays.

Brain Sci. 2022-11-19

引用本文的文献

[1]
Exploring the Role of Oral Microbiota in the Pathophysiology and Treatment of Bruxism.

FASEB J. 2025-9-15

[2]
Microbial diversity in drug-naïve Parkinson's disease patients.

PLoS One. 2025-8-18

[3]
Association between oral dysbiosis and Parkinson's disease: a systematic review.

Front Cell Infect Microbiol. 2025-5-13

[4]
Intranasal Transplantation of Microbiota Derived from Parkinson's Disease Mice Induced Astrocyte Activation and Neurodegenerative Pathology from Nose to Brain.

Brain Sci. 2025-4-23

[5]
Altered nasal and oral microbiomes define pediatric sickle cell disease.

mSphere. 2025-6-25

[6]
Comparison of phage and plasmid populations in the gut microbiota between Parkinson's disease patients and controls.

Sci Rep. 2025-4-21

[7]
Oral health implications in Parkinson's disease.

NPJ Parkinsons Dis. 2025-4-11

[8]
Can salivary and skin microbiome become a biodetector for aging-associated diseases? Current insights and future perspectives.

Front Aging. 2024-10-17

[9]
Oral and gut microbiome profiles in people with early idiopathic Parkinson's disease.

Commun Med (Lond). 2024-10-23

[10]
Metagenome-assembled microbial genomes from Parkinson's disease fecal samples.

Sci Rep. 2024-8-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索